Skip to main content
Top
Published in: Knee Surgery, Sports Traumatology, Arthroscopy 12/2023

Open Access 22-09-2023 | Osteoarthrosis | KNEE

Mesenchymal stem cell implantation provides short-term clinical improvement and satisfactory cartilage restoration in patients with knee osteoarthritis but the evidence is limited: a systematic review performed by the early-osteoarthritis group of ESSKA-European knee associates section

Authors: Hamid Rahmatullah Bin Abd Razak, Katia Corona, Trifon Totlis, Li Yi Tammy Chan, Jose Filipe Salreta, Obeida Sleiman, Michele Vasso, Mike H. Baums

Published in: Knee Surgery, Sports Traumatology, Arthroscopy | Issue 12/2023

Login to get access

Abstract

Purpose

Implantation of mesenchymal stem cells (MSCs) is a potential cell-based modality for cartilage repair. Currently, its clinical use largely surrounds focal cartilage defect repair and intra-articular injections in knee osteoarthritis. The MSCs’ implantation efficacy as a treatment option for osteoarthritis remains contentious. This systematic review aims to evaluate studies that focused on MSCs implantation in patients with knee OA to provide a summary of this treatment option outcomes.

Methods

A systematic search was performed in PubMed (Medline), Scopus, Cinahl, and the Cochrane Library. Original studies investigating outcomes of MSCs implantations in patients with knee OA were included. Data on clinical outcomes using subjective scores, radiological outcomes, and second-look arthroscopy gradings were extracted.

Results

Nine studies were included in this review. In all included studies, clinical outcome scores revealed significantly improved functionality and better postoperative pain scores at 2–3 years follow-up. Improved cartilage volume and quality at the lesion site was observed in five studies that included a postoperative magnetic resonance imaging assessment and studies that performed second-look arthroscopy. No major complications or tumorigenesis occurred. Outcomes were consistent in both single MSCs implantation and concurrent HTO with MSCs implantation in cases with excessive varus deformity.

Conclusion

According to the available literature, MSCs implantation in patients with mild to moderate knee osteoarthritis is safe and provides short-term clinical improvement and satisfactory cartilage restoration, either as a standalone procedure or combined with HTO in cases with axial deformity. However, the evidence is limited due to the high heterogeneity among studies and the insufficient number of studies including a control group and mid-term outcomes.

Level of evidence

IV.
Literature
1.
go back to reference Barry F, Murphy M (2013) Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol 9:584–594CrossRefPubMed Barry F, Murphy M (2013) Mesenchymal stem cells in joint disease and repair. Nat Rev Rheumatol 9:584–594CrossRefPubMed
2.
go back to reference Bode L, Eberbach H, Brenner AS, Kloos F, Niemeyer P, Schmal H et al (2022) Ten-year survival rates after high tibial osteotomy using angular stable internal plate fixation: case series with subgroup analysis of outcomes after combined autologous chondrocyte implantation and high tibial osteotomy. Orthop J Sports Med 10:23259671221078004CrossRefPubMedPubMedCentral Bode L, Eberbach H, Brenner AS, Kloos F, Niemeyer P, Schmal H et al (2022) Ten-year survival rates after high tibial osteotomy using angular stable internal plate fixation: case series with subgroup analysis of outcomes after combined autologous chondrocyte implantation and high tibial osteotomy. Orthop J Sports Med 10:23259671221078004CrossRefPubMedPubMedCentral
3.
go back to reference Bonasia DE, Dettoni F, Sito G, Blonna D, Marmotti A, Bruzzone M et al (2014) Medial opening wedge high tibial osteotomy for medial compartment overload/arthritis in the varus knee: prognostic factors. Am J Sports Med 42:690–698CrossRefPubMed Bonasia DE, Dettoni F, Sito G, Blonna D, Marmotti A, Bruzzone M et al (2014) Medial opening wedge high tibial osteotomy for medial compartment overload/arthritis in the varus knee: prognostic factors. Am J Sports Med 42:690–698CrossRefPubMed
4.
go back to reference Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A et al (2019) Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med 14:213–230CrossRefPubMed Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A et al (2019) Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med 14:213–230CrossRefPubMed
5.
go back to reference Gomoll AH, Angele P, Condello V, Madonna V, Madry H, Randelli P et al (2016) Load distribution in early osteoarthritis. Knee Surg Sports Traumatol Arthrosc 24:1815–1825CrossRefPubMed Gomoll AH, Angele P, Condello V, Madonna V, Madry H, Randelli P et al (2016) Load distribution in early osteoarthritis. Knee Surg Sports Traumatol Arthrosc 24:1815–1825CrossRefPubMed
6.
go back to reference Gong J, Fairley J, Cicuttini FM, Hussain SM, Vashishtha R, Chou L et al (2021) Effect of stem cell injections on osteoarthritis-related structural outcomes: a systematic review. J Rheumatol 48:585–597CrossRefPubMed Gong J, Fairley J, Cicuttini FM, Hussain SM, Vashishtha R, Chou L et al (2021) Effect of stem cell injections on osteoarthritis-related structural outcomes: a systematic review. J Rheumatol 48:585–597CrossRefPubMed
7.
go back to reference Harris JD, McNeilan R, Siston RA, Flanigan DC (2013) Survival and clinical outcome of isolated high tibial osteotomy and combined biological knee reconstruction. Knee 20:154–161CrossRefPubMed Harris JD, McNeilan R, Siston RA, Flanigan DC (2013) Survival and clinical outcome of isolated high tibial osteotomy and combined biological knee reconstruction. Knee 20:154–161CrossRefPubMed
8.
go back to reference Hernigou P, Bouthors C, Bastard C, Flouzat Lachaniette CH, Rouard H, Dubory A (2021) Subchondral bone or intra-articular injection of bone marrow concentrate mesenchymal stem cells in bilateral knee osteoarthritis: what better postpone knee arthroplasty at fifteen years? a randomized study. Int Orthop 45:391–399CrossRefPubMed Hernigou P, Bouthors C, Bastard C, Flouzat Lachaniette CH, Rouard H, Dubory A (2021) Subchondral bone or intra-articular injection of bone marrow concentrate mesenchymal stem cells in bilateral knee osteoarthritis: what better postpone knee arthroplasty at fifteen years? a randomized study. Int Orthop 45:391–399CrossRefPubMed
9.
go back to reference Horie M, Choi H, Lee RH, Reger RL, Ylostalo J, Muneta T et al (2012) Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that enhances expression of type II collagen. Osteoarthritis Cartilage 20:1197–1207CrossRefPubMedPubMedCentral Horie M, Choi H, Lee RH, Reger RL, Ylostalo J, Muneta T et al (2012) Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that enhances expression of type II collagen. Osteoarthritis Cartilage 20:1197–1207CrossRefPubMedPubMedCentral
10.
go back to reference Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12CrossRefPubMed Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12CrossRefPubMed
12.
go back to reference Jeong SY, Kim DH, Ha J, Jin HJ, Kwon SJ, Chang JW et al (2013) Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation. Stem Cells 31:2136–2148CrossRefPubMed Jeong SY, Kim DH, Ha J, Jin HJ, Kwon SJ, Chang JW et al (2013) Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation. Stem Cells 31:2136–2148CrossRefPubMed
13.
go back to reference Kahlenberg CA, Nwachukwu BU, Hamid KS, Steinhaus ME, Williams RJ III (2017) Analysis of outcomes for high tibial osteotomies performed with cartilage restoration techniques. Arthroscopy 33:486–492CrossRefPubMed Kahlenberg CA, Nwachukwu BU, Hamid KS, Steinhaus ME, Williams RJ III (2017) Analysis of outcomes for high tibial osteotomies performed with cartilage restoration techniques. Arthroscopy 33:486–492CrossRefPubMed
14.
go back to reference Katz BP, Freund DA, Heck DA, Dittus RS, Paul JE, Wright J et al (1996) Demographic variation in the rate of knee replacement: a multi-year analysis. Health Serv Res 31:125–140PubMedPubMedCentral Katz BP, Freund DA, Heck DA, Dittus RS, Paul JE, Wright J et al (1996) Demographic variation in the rate of knee replacement: a multi-year analysis. Health Serv Res 31:125–140PubMedPubMedCentral
15.
go back to reference Kim YS, Choi YJ, Lee SW, Kwon OR, Suh DS, Heo DB et al (2016) Assessment of clinical and MRI outcomes after mesenchymal stem cell implantation in patients with knee osteoarthritis: a prospective study. Osteoarthr Carti 24:237–245CrossRef Kim YS, Choi YJ, Lee SW, Kwon OR, Suh DS, Heo DB et al (2016) Assessment of clinical and MRI outcomes after mesenchymal stem cell implantation in patients with knee osteoarthritis: a prospective study. Osteoarthr Carti 24:237–245CrossRef
16.
go back to reference Kim YS, Chung PK, Suh DS, Heo DB, Tak DH, Koh YG (2020) Implantation of mesenchymal stem cells in combination with allogenic cartilage improves cartilage regeneration and clinical outcomes in patients with concomitant high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc 28:544–554CrossRefPubMed Kim YS, Chung PK, Suh DS, Heo DB, Tak DH, Koh YG (2020) Implantation of mesenchymal stem cells in combination with allogenic cartilage improves cartilage regeneration and clinical outcomes in patients with concomitant high tibial osteotomy. Knee Surg Sports Traumatol Arthrosc 28:544–554CrossRefPubMed
17.
go back to reference Kim YS, Koh YG (2018) Comparative matched-pair analysis of open-wedge high tibial osteotomy with versus without an injection of adipose-derived mesenchymal stem cells for varus knee osteoarthritis: clinical and second-look arthroscopic results. Am J Sports Med 46:2669–2677CrossRefPubMed Kim YS, Koh YG (2018) Comparative matched-pair analysis of open-wedge high tibial osteotomy with versus without an injection of adipose-derived mesenchymal stem cells for varus knee osteoarthritis: clinical and second-look arthroscopic results. Am J Sports Med 46:2669–2677CrossRefPubMed
18.
go back to reference Kim YS, Kwon OR, Choi YJ, Suh DS, Heo DB, Koh YG (2015) Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis. Am J Sports Med 43:2738–2746CrossRefPubMed Kim YS, Kwon OR, Choi YJ, Suh DS, Heo DB, Koh YG (2015) Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis. Am J Sports Med 43:2738–2746CrossRefPubMed
19.
go back to reference Kim YS, Suh DS, Tak DH, Chung PK, Koh YG (2020) Mesenchymal Stem cell implantation in knee osteoarthritis: midterm outcomes and survival analysis in 467 patients. Orthop J Sports Med 8:2325967120969189CrossRefPubMedPubMedCentral Kim YS, Suh DS, Tak DH, Chung PK, Koh YG (2020) Mesenchymal Stem cell implantation in knee osteoarthritis: midterm outcomes and survival analysis in 467 patients. Orthop J Sports Med 8:2325967120969189CrossRefPubMedPubMedCentral
20.
go back to reference Kim YS, Suh DS, Tak DH, Chung PK, Kwon YB, Kim TY et al (2021) Factors influencing clinical and mri outcomes of mesenchymal stem cell implantation with concomitant high tibial osteotomy for varus knee osteoarthritis. Orthop J Sports Med 9:2325967120979987CrossRefPubMedPubMedCentral Kim YS, Suh DS, Tak DH, Chung PK, Kwon YB, Kim TY et al (2021) Factors influencing clinical and mri outcomes of mesenchymal stem cell implantation with concomitant high tibial osteotomy for varus knee osteoarthritis. Orthop J Sports Med 9:2325967120979987CrossRefPubMedPubMedCentral
21.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefPubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefPubMedPubMedCentral
22.
go back to reference Maheshwer B, Polce EM, Paul K, Williams BT, Wolfson TS, Yanke A et al (2021) Regenerative potential of mesenchymal stem cells for the treatment of knee osteoarthritis and chondral defects: a systematic review and meta-analysis. Arthroscopy 37:362–378CrossRefPubMed Maheshwer B, Polce EM, Paul K, Williams BT, Wolfson TS, Yanke A et al (2021) Regenerative potential of mesenchymal stem cells for the treatment of knee osteoarthritis and chondral defects: a systematic review and meta-analysis. Arthroscopy 37:362–378CrossRefPubMed
23.
go back to reference Muthu S, Mir AA, Kumar R, Yadav V, Jeyaraman M, Khanna M (2022) What is the clinically significant ideal mesenchymal stromal cell count in the management of osteoarthritis of the knee?-meta-analysis of randomized controlled trials. J Clin Orthop Trauma 25:101744CrossRefPubMed Muthu S, Mir AA, Kumar R, Yadav V, Jeyaraman M, Khanna M (2022) What is the clinically significant ideal mesenchymal stromal cell count in the management of osteoarthritis of the knee?-meta-analysis of randomized controlled trials. J Clin Orthop Trauma 25:101744CrossRefPubMed
24.
go back to reference Nöth U, Steinert AF, Tuan RS (2008) Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 4:371–380CrossRefPubMed Nöth U, Steinert AF, Tuan RS (2008) Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol 4:371–380CrossRefPubMed
25.
go back to reference Park YB, Ha CW, Lee CH, Yoon YC, Park YG (2017) Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof-of-Concept with 7 years of extended follow-Up. Stem Cells Transl Med 6:613–621CrossRefPubMed Park YB, Ha CW, Lee CH, Yoon YC, Park YG (2017) Cartilage regeneration in osteoarthritic patients by a composite of allogeneic umbilical cord blood-derived mesenchymal stem cells and hyaluronate hydrogel: results from a clinical trial for safety and proof-of-Concept with 7 years of extended follow-Up. Stem Cells Transl Med 6:613–621CrossRefPubMed
26.
go back to reference Pers YM, Ruiz M, Noël D, Jorgensen C (2015) Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthr Cartil 23:2027–2035CrossRef Pers YM, Ruiz M, Noël D, Jorgensen C (2015) Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives. Osteoarthr Cartil 23:2027–2035CrossRef
27.
go back to reference Rossi MJ, Lubowitz JH, Guttmann D (2002) Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med 30:152CrossRefPubMed Rossi MJ, Lubowitz JH, Guttmann D (2002) Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med 30:152CrossRefPubMed
28.
go back to reference Schuster P, Geßlein M, Schlumberger M, Mayer P, Mayr R, Oremek D et al (2018) Ten-year results of medial open-wedge high tibial osteotomy and chondral resurfacing in severe medial osteoarthritis and varus malalignment. Am J Sports Med 46:1362–1370CrossRefPubMed Schuster P, Geßlein M, Schlumberger M, Mayer P, Mayr R, Oremek D et al (2018) Ten-year results of medial open-wedge high tibial osteotomy and chondral resurfacing in severe medial osteoarthritis and varus malalignment. Am J Sports Med 46:1362–1370CrossRefPubMed
29.
go back to reference Song JS, Hong KT, Kim NM, Jung JY, Park HS, Lee SH et al (2020) Implantation of allogenic umbilical cord blood-derived mesenchymal stem cells improves knee osteoarthritis outcomes: two-year follow-up. Regen Ther 14:32–39CrossRefPubMedPubMedCentral Song JS, Hong KT, Kim NM, Jung JY, Park HS, Lee SH et al (2020) Implantation of allogenic umbilical cord blood-derived mesenchymal stem cells improves knee osteoarthritis outcomes: two-year follow-up. Regen Ther 14:32–39CrossRefPubMedPubMedCentral
30.
go back to reference Song JS, Hong KT, Kong CG, Kim NM, Jung JY, Park HS et al (2020) High tibial osteotomy with human umbilical cord blood-derived mesenchymal stem cells implantation for knee cartilage regeneration. World J Stem Cells 12:514–526CrossRefPubMedPubMedCentral Song JS, Hong KT, Kong CG, Kim NM, Jung JY, Park HS et al (2020) High tibial osteotomy with human umbilical cord blood-derived mesenchymal stem cells implantation for knee cartilage regeneration. World J Stem Cells 12:514–526CrossRefPubMedPubMedCentral
31.
go back to reference Song Y, Zhang J, Xu H, Lin Z, Chang H, Liu W et al (2020) Mesenchymal stem cells in knee osteoarthritis treatment: a systematic review and meta-analysis. J Orthop Translat 24:121–130CrossRefPubMedPubMedCentral Song Y, Zhang J, Xu H, Lin Z, Chang H, Liu W et al (2020) Mesenchymal stem cells in knee osteoarthritis treatment: a systematic review and meta-analysis. J Orthop Translat 24:121–130CrossRefPubMedPubMedCentral
32.
go back to reference Vézina Audette R, Lavoie-Lamoureux A, Lavoie JP, Laverty S (2013) Inflammatory stimuli differentially modulate the transcription of paracrine signaling molecules of equine bone marrow multipotent mesenchymal stromal cells. Osteoarthritis Cartilage 21:1116–1124CrossRefPubMed Vézina Audette R, Lavoie-Lamoureux A, Lavoie JP, Laverty S (2013) Inflammatory stimuli differentially modulate the transcription of paracrine signaling molecules of equine bone marrow multipotent mesenchymal stromal cells. Osteoarthritis Cartilage 21:1116–1124CrossRefPubMed
33.
go back to reference Wang AT, Feng Y, Jia HH, Zhao M, Yu H (2019) Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: a concise review. World J Stem Cells 11:222–235CrossRefPubMedPubMedCentral Wang AT, Feng Y, Jia HH, Zhao M, Yu H (2019) Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: a concise review. World J Stem Cells 11:222–235CrossRefPubMedPubMedCentral
34.
go back to reference Wang F, Ma W, Chen J, Cong W, Zhang Y, Yu T et al (2022) Prognostic factors for medial open-wedge high tibial osteotomy with spacer implantation in patients with medial compartmental knee osteoarthritis. J Orthop Surg Res 17:50CrossRefPubMedPubMedCentral Wang F, Ma W, Chen J, Cong W, Zhang Y, Yu T et al (2022) Prognostic factors for medial open-wedge high tibial osteotomy with spacer implantation in patients with medial compartmental knee osteoarthritis. J Orthop Surg Res 17:50CrossRefPubMedPubMedCentral
35.
go back to reference Wu L, Prins HJ, Helder MN, van Blitterswijk CA, Karperien M (2012) Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources. Tissue Eng Part A 18:1542–1551CrossRefPubMed Wu L, Prins HJ, Helder MN, van Blitterswijk CA, Karperien M (2012) Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources. Tissue Eng Part A 18:1542–1551CrossRefPubMed
36.
go back to reference Yang HY, Song EK, Kang SJ, Kwak WK, Kang JK, Seon JK (2022) Allogenic umbilical cord blood-derived mesenchymal stromal cell implantation was superior to bone marrow aspirate concentrate augmentation for cartilage regeneration despite similar clinical outcomes. Knee Surg Sports Traumatol Arthrosc 30:208–218CrossRefPubMed Yang HY, Song EK, Kang SJ, Kwak WK, Kang JK, Seon JK (2022) Allogenic umbilical cord blood-derived mesenchymal stromal cell implantation was superior to bone marrow aspirate concentrate augmentation for cartilage regeneration despite similar clinical outcomes. Knee Surg Sports Traumatol Arthrosc 30:208–218CrossRefPubMed
Metadata
Title
Mesenchymal stem cell implantation provides short-term clinical improvement and satisfactory cartilage restoration in patients with knee osteoarthritis but the evidence is limited: a systematic review performed by the early-osteoarthritis group of ESSKA-European knee associates section
Authors
Hamid Rahmatullah Bin Abd Razak
Katia Corona
Trifon Totlis
Li Yi Tammy Chan
Jose Filipe Salreta
Obeida Sleiman
Michele Vasso
Mike H. Baums
Publication date
22-09-2023
Publisher
Springer Berlin Heidelberg
Published in
Knee Surgery, Sports Traumatology, Arthroscopy / Issue 12/2023
Print ISSN: 0942-2056
Electronic ISSN: 1433-7347
DOI
https://doi.org/10.1007/s00167-023-07575-w

Other articles of this Issue 12/2023

Knee Surgery, Sports Traumatology, Arthroscopy 12/2023 Go to the issue